BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ERG, P11308, 2078 AND Treatment
8 results:

  • 1. Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor.
    Ye H; Lin M; Li R; Qin S; Hou G; Chen H; Li X
    J Ovarian Res; 2021 Jan; 14(1):21. PubMed ID: 33509230
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
    Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
    BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
    Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
    Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Olaparib for Maintenance treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive ovarian, Fallopian Tube and Peritoneal cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Tappenden P; Harnan S; Ren S; Thokala P; Wong R; Mukuria C; Green C; Pledge S; Tidy J
    Pharmacoeconomics; 2017 Jan; 35(1):97-109. PubMed ID: 27506954
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.
    Micci F; Panagopoulos I; Thorsen J; Davidson B; Tropé CG; Heim S
    PLoS Biol; 2014 Feb; 12(2):e1001784. PubMed ID: 24504521
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trabectedin for the treatment of relapsed ovarian cancer.
    Papaioannou D; Rafia R; Stevenson MD; Stevens JW; Evans P
    Health Technol Assess; 2011 May; 15 Suppl 1():69-75. PubMed ID: 21609655
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Borderline ovarian tumors and global radiation in relation with climate change impact].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.